Adding Evinacumab to Care Plan Can Significantly Increase HoFH Life Expectancy
https://pixabay.com/en/doctor-blood-life-veins-pain-2346235/

Adding Evinacumab to Care Plan Can Significantly Increase HoFH Life Expectancy

In the average person, you would expect to see normal to near-optimal low-density lipoprotein (LDL) cholesterol levels sitting at 129 mg/DL or lower; levels under 100 are seen as healthier.…

Continue Reading Adding Evinacumab to Care Plan Can Significantly Increase HoFH Life Expectancy
Invex Therapeutics Hits Recruitment Roadblocks in IIH Study
Source: pixabay.com

Invex Therapeutics Hits Recruitment Roadblocks in IIH Study

When biopharmaceutical company Invex Therapeutics (“Invex”) first decided to launch a clinical trial to evaluate Presendin (sustained-release exenatide) for idiopathic intracranial hypertension (IIH), the company felt excited. Presendin is a…

Continue Reading Invex Therapeutics Hits Recruitment Roadblocks in IIH Study